DP
ATYR

Diadema Partners’s aTyr Pharma ATYR Stock Holding History

Diadema Partners’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.46K Hold
12,500
– – ﹤0.01% 145
2026
Q1 		$9.75K Buy
12,500
+700
+6% +$591 ﹤0.01% 139
2025
Q4 		$9.24K Sell
11,800
-64,400
-85% -$52.9K ﹤0.01% 143
2025
Q3 		$55K Hold
76,200
– – 0.01% 123
2025
Q2 		$386K Buy
76,200
+64,400
+546% +$253K 0.12% 81
2025
Q1 		$35.6K Buy
+11,800
New +$43K 0.01% 99

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return